| Substance | Condition | Seq | Src | PMID | Dtl | Title |
| Silibinin | Acute Myeloid Leukemia | 2 | PM | 26148599 | 📋 | Enhancement of the cytotoxic effects of Cytarabine in synergism with Hesperidine and Silibinin in Acute Myeloid Leukemia: An in-vitro approach |
| Silibinin | Acute Myeloid Leukemia | 1 | PM | 20661831 | 📋 | Distinct Combinatorial Effects of the Plant Polyphenols Curcumin, Carnosic Acid, and Silibinin on Proliferation and Apoptosis in Acute Myeloid Leukemia Cells |
| Silibinin | Allergic Disease | 1 | PM | 24045679 | 📋 | Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells |
| Silibinin | Anaphylaxis | 1 | PM | 37115717 | 📋 | Silibinin attenuated pseudo-allergic reactions and mast cell degranulation via PLCγ and PI3K/Akt signaling pathway |
| Silibinin | Autoimmune Disease | 3 | PM | 36142329 | 📋 | Human Monocyte-Derived Dendritic Cells Are the Pharmacological Target of the Immunosuppressant Flavonoid Silibinin |
| Silibinin | Autoimmune Disease | 1 | PM | 34557140 | 📋 | Silybin Alleviates Experimental Autoimmune Encephalomyelitis by Suppressing Dendritic Cell Activation and Th17 Cell Differentiation |
| Silibinin | Autoimmune Disease | 2 | PM | 30174672 | 📋 | The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis |
| Silibinin | HIV/AIDS | 1 | PM | 28619387 | 📋 | Evaluation of ameliorative ability of Silibinin against zidovudine and isoniazid-induced hepatotoxicity and hyperlipidaemia in rats: Role of Silibinin in Phase I and II drug metabolism |
| Silibinin | Immune System Regulation | 1 | PM | 30174672 | 📋 | The Natural Agonist of Estrogen Receptor β Silibinin Plays an Immunosuppressive Role Representing a Potential Therapeutic Tool in Rheumatoid Arthritis |
| Silibinin | Inflammation | 5 | PM | 38247522 | 📋 | Silymarin and Inflammation: Food for Thoughts |
| Silibinin | Inflammation | 4 | PM | 37886956 | 📋 | Inhibition of Phagocytosis by Silibinin in Mouse Macrophages |
| Silibinin | Inflammation | 3 | PM | 35844639 | 📋 | Enhanced Anti-Inflammatory Effects of Silibinin and Capsaicin Combination in Lipopolysaccharide-Induced RAW264.7 Cells by Inhibiting NF-κB and MAPK Activation |
| Silibinin | Inflammation | 2 | PM | 32890914 | 📋 | Synergistic anti-inflammatory effects of silibinin and thymol combination on LPS-induced RAW264.7 cells by inhibition of NF-κB and MAPK activation |
| Silibinin | Inflammation | 1 | PM | 31973745 | 📋 | Silibinin attenuates adipose tissue inflammation and reverses obesity and its complications in diet-induced obesity model in mice |
| Silibinin | Inflammation | 6 | PM | 24045679 | 📋 | Silibinin inhibits the production of pro-inflammatory cytokines through inhibition of NF-κB signaling pathway in HMC-1 human mast cells |
| Silibinin | Lymphoma | 1 | PM | 35093875 | 📋 | The Natural Estrogen Receptor Beta Agonist Silibinin as a Promising Therapeutic Tool in Diffuse Large B-cell Lymphoma |
| Silibinin | Sepsis | 2 | PM | 36693441 | 📋 | Identification of CCR2 as a hub in septic myocardial injury and cardioprotection of silibinin |
| Silibinin | Sepsis | 1 | PM | 35640818 | 📋 | Silibinin protects against sepsis and septic myocardial injury in an NR1H3-dependent pathway |
